Suppr超能文献

甲硫噻吨和麦角酸二乙胺对体外5-羟色胺释放及体内5-羟色胺合成的影响:与5-羟色胺自身受体功能的可能关系。

Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.

作者信息

Pettibone D J, Pflueger A B

出版信息

J Neurochem. 1984 Jul;43(1):83-90. doi: 10.1111/j.1471-4159.1984.tb06681.x.

Abstract

An in vitro system characterizing the presynaptic serotonin (5-HT) autoreceptor which controls the release of 5-HT from rat brain slices is described. Using this system, methiothepin (1-10 microM) demonstrated 5-HT autoreceptor antagonist activity by enhancing 5-HT release, while several recognized postsynaptic 5-HT receptor antagonists were inactive: mianserin, cinanserin, cyproheptadine, methysergide. The activity of methiothepin was highest in hypothalamic slices and lowest in striatal slices and was inhibited by the autoreceptor agonists lysergic acid diethylamide (LSD) and 5-methoxytryptamine (5-MT). The reversal of the methiothepin-enhanced 5-HT release from hypothalamic slices by LSD was not influenced by 0.3 microM tetrodotoxin. The peripheral administration of LSD to rats has been shown to reduce 5-HT synthesis and release by a mechanism thought to involve, in part, an autoreceptor-mediated reduction in impulse flow of 5-HT neurons. In the present experiments, intraperitoneal injection of methiothepin antagonized the LSD-induced reduction in hypothalamic 5-HT synthesis (5-hydroxytryptophan accumulation) while exerting no influence by itself. Conversely, compounds which were not active as 5-HT autoreceptor antagonists in vitro (i.e., cyproheptadine, methysergide, cinanserin) did not influence the effect of LSD on 5-HT synthesis. Further, the reduction in 5-hydroxytryptophan (5-HTP) accumulation by LSD showed regional differences in inhibition by methiothepin (hypothalamus greater than cortex greater than striatum) which paralleled the autoreceptor antagonist activity of methiothepin in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本文描述了一种体外系统,该系统可表征控制大鼠脑片5-羟色胺(5-HT)释放的突触前5-HT自身受体。利用该系统,甲硫噻庚因(1-10微摩尔)通过增强5-HT释放表现出5-HT自身受体拮抗剂活性,而几种公认的突触后5-HT受体拮抗剂则无活性:米安色林、西那色林、赛庚啶、美西麦角。甲硫噻庚因的活性在下丘脑切片中最高,在纹状体切片中最低,并被自身受体激动剂麦角酰二乙胺(LSD)和5-甲氧基色胺(5-MT)抑制。LSD对甲硫噻庚因增强的下丘脑切片5-HT释放的逆转不受0.3微摩尔河豚毒素影响。已表明向大鼠外周给予LSD可通过一种部分涉及自身受体介导的5-HT神经元冲动流减少的机制来降低5-HT合成和释放。在本实验中,腹腔注射甲硫噻庚因可拮抗LSD诱导的下丘脑5-HT合成减少(5-羟色氨酸积累),而其本身无影响。相反,在体外不作为5-HT自身受体拮抗剂的化合物(即赛庚啶、美西麦角、西那色林)不影响LSD对5-HT合成的作用。此外,LSD导致的5-羟色氨酸(5-HTP)积累减少在甲硫噻庚因抑制方面表现出区域差异(下丘脑>皮层>纹状体),这与甲硫噻庚因在体外的自身受体拮抗剂活性平行。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验